Evidence map›Paper›PMID 37863612›Full record

ReviewSeminars in vascular surgery2023

Artificial intelligence in clinical workflow processes in vascular surgery and beyond.

Shernaz S Dossabhoy, Vy T Ho, Elsie G Ross, Fatima Rodriguez, Shipra Arya

Abstract readReview
In one paragraph

Review in Seminars in vascular surgery, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Humans use tools: From handcrafted tools to artificial intelligence.Journal of vascular surgery. Venous and lymphatic disorders · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Shernaz S DossabhoyDivision of Vascular Surgery, Stanford University School of Medicine, 780 Welch Road, CJ350, MC 5639, Palo Alto, CA, 94304.
Vy T HoDivision of Vascular Surgery, Stanford University School of Medicine, 780 Welch Road, CJ350, MC 5639, Palo Alto, CA, 94304.
Elsie G RossDivision of Vascular Surgery, Stanford University School of Medicine, 780 Welch Road, CJ350, MC 5639, Palo Alto, CA, 94304.
Fatima RodriguezDivision of Cardiovascular Medicine and Cardiovascular Institute, Stanford University, CA.
Shipra AryaDivision of Vascular Surgery, Stanford University School of Medicine, 780 Welch Road, CJ350, MC 5639, Palo Alto, CA, 94304. Electronic address: sarya1@stanford.edu.

Funding

Training In Cardiovascular Physiology & PharmacologyT32HL007444 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Ju Chen, Robert Scott Ross · 1985 to 2026
$11.1M
UCSD PRIDE Faculty Development Program in Cardiovascular SciencesR25HL145817 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Robert Scott Ross, Joann Trejo · 2019 to 2026
$3.3M
Adherence Determinants in the Health Electronic Record Evaluation of Statins (ADHERES)R01HL168188 · NHLBI · STANFORD UNIVERSITY · PI Fatima Rodriguez · 2024 to 2026
$2.1M
SURPASS: (Statin Use and Risk Prediction of Atherosclerotic Cardiovascular Disease in minority Subgroups)K01HL144607 · NHLBI · STANFORD UNIVERSITY · PI RODRIGUEZ, FATIMA · 2019 to 2023
$856k
AHRQ HHS T32 HS026128NHLBI NIH HHS K01 HL144607NHLBI NIH HHS R01 HL168188NHLBI NIH HHS R25 HL145817NHLBI NIH HHS T32 HL007444
6 · The paper itself

Abstract

In the past decade, artificial intelligence (AI)-based applications have exploded in health care. In cardiovascular disease, and vascular surgery specifically, AI tools such as machine learning, natural language processing, and deep neural networks have been applied to automatically detect underdiagnosed diseases, such as peripheral artery disease, abdominal aortic aneurysms, and atherosclerotic cardiovascular disease. In addition to disease detection and risk stratification, AI has been used to identify guideline-concordant statin therapy use and reasons for nonuse, which has important implications for population-based cardiovascular disease health. Although many studies highlight the potential applications of AI, few address true clinical workflow implementation of available AI-based tools. Specific examples, such as determination of optimal statin treatment based on individual patient risk factors and enhancement of intraoperative fluoroscopy and ultrasound imaging, demonstrate the potential promise of AI integration into clinical workflow. Many challenges to AI implementation in health care remain, including data interoperability, model bias and generalizability, prospective evaluation, privacy and security, and regulation. Multidisciplinary and multi-institutional collaboration, as well as adopting a framework for integration, will be critical for the successful implementation of AI tools into clinical practice.

Indexed as

Hydroxymethylglutaryl-CoA Reductase InhibitorsPeripheral Arterial DiseaseArtificial IntelligenceHumansNeural Networks, ComputerWorkflowHydroxymethylglutaryl-CoA Reductase InhibitorsAbdominal aortic aneurysmArtificial intelligenceAtherosclerotic cardiovascular diseaseMachine learningPeripheral artery disease

Identifiers

PMID37863612
PMCPMC10956485

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.